BIOC fundamentals
GLAXO SMITH KLINE financial statements, including revenue, expenses, and profit
The total revenue of BIOC for the last quarter is 993.91 M EGP, and it's 39.24% higher compared to the previous quarter. The net income of Q1 25 is 59.12 M EGP.
Q2 '14
Q3 '14
Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q1 '25
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q2 '14
Q3 '14
Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q1 '25
TTM